{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T00:02:20Z","timestamp":1790899340660,"version":"4.1.0"},"reference-count":37,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2022,2,23]],"date-time":"2022-02-23T00:00:00Z","timestamp":1645574400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2022,2,23]],"date-time":"2022-02-23T00:00:00Z","timestamp":1645574400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/501100001809","name":"national natural science foundation of china","doi-asserted-by":"publisher","award":["81820092"],"award-info":[{"award-number":["81820092"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Biol Rep"],"published-print":{"date-parts":[[2022,6]]},"DOI":"10.1007\/s11033-022-07253-z","type":"journal-article","created":{"date-parts":[[2022,2,23]],"date-time":"2022-02-23T06:12:39Z","timestamp":1645596759000},"page":"4205-4216","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":26,"title":["miR-146a contributes to atherosclerotic plaque stability by regulating the expression of TRAF6 and IRAK-1"],"prefix":"10.1007","volume":"49","author":[{"given":"Tianshu","family":"Chu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xu","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhimin","family":"Ruan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liyong","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mingli","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2823-0046","authenticated-orcid":false,"given":"Guofu","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,2,23]]},"reference":[{"issue":"2","key":"7253_CR1","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1161\/circresaha.118.313591","volume":"124","author":"D Wolf","year":"2019","unstructured":"Wolf D, Ley K (2019) Immunity and inflammation in atherosclerosis. Circ Res 124(2):315\u2013327. https:\/\/doi.org\/10.1161\/circresaha.118.313591","journal-title":"Circ Res"},{"issue":"43","key":"7253_CR2","doi-asserted-by":"publisher","first-page":"3195","DOI":"10.1093\/eurheartj\/ehx362%","volume":"38","author":"NVK Pothineni","year":"2017","unstructured":"Pothineni NVK et al (2017) Infections, atherosclerosis, and coronary heart disease. Eur Heart J 38(43):3195\u20133201. https:\/\/doi.org\/10.1093\/eurheartj\/ehx362%","journal-title":"Eur Heart J"},{"issue":"3","key":"7253_CR3","doi-asserted-by":"publisher","first-page":"184","DOI":"10.1016\/j.smim.2015.03.013","volume":"27","author":"J Viola","year":"2015","unstructured":"Viola J, Soehnlein O (2015) Atherosclerosis\u2014a matter of unresolved inflammation. Semin Immunol 27(3):184\u2013193. https:\/\/doi.org\/10.1016\/j.smim.2015.03.013","journal-title":"Semin Immunol"},{"issue":"3\u20134","key":"7253_CR4","doi-asserted-by":"publisher","first-page":"485","DOI":"10.1007\/s00424-017-1941-y","volume":"469","author":"C Cochain","year":"2017","unstructured":"Cochain C, Zernecke A (2017) Macrophages in vascular inflammation and atherosclerosis. Pflugers Arch 469(3\u20134):485\u2013499. https:\/\/doi.org\/10.1007\/s00424-017-1941-y","journal-title":"Pflugers Arch"},{"key":"7253_CR5","doi-asserted-by":"publisher","DOI":"10.3390\/ijms18102034","author":"MY Wu","year":"2017","unstructured":"Wu MY et al (2017) New insights into the role of inflammation in the pathogenesis of atherosclerosis. Int J Mol Sci. https:\/\/doi.org\/10.3390\/ijms18102034","journal-title":"Int J Mol Sci"},{"issue":"6","key":"7253_CR6","doi-asserted-by":"publisher","first-page":"610","DOI":"10.1056\/NEJMra052723","volume":"354","author":"IF Charo","year":"2006","unstructured":"Charo IF, Ransohoff RM (2006) The many roles of chemokines and chemokine receptors in inflammation. N Engl J Med 354(6):610\u2013621. https:\/\/doi.org\/10.1056\/NEJMra052723","journal-title":"N Engl J Med"},{"issue":"4","key":"7253_CR7","doi-asserted-by":"publisher","first-page":"653","DOI":"10.1161\/circresaha.115.306256","volume":"118","author":"I Tabas","year":"2016","unstructured":"Tabas I, Bornfeldt KE (2016) Macrophage phenotype and function in different stages of atherosclerosis. Circ Res 118(4):653\u2013667. https:\/\/doi.org\/10.1161\/circresaha.115.306256","journal-title":"Circ Res"},{"issue":"2","key":"7253_CR8","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1097\/mol.0000000000000394","volume":"28","author":"MM Kavurma","year":"2017","unstructured":"Kavurma MM, Rayner KJ, Karunakaran D (2017) The walking dead: macrophage inflammation and death in atherosclerosis. Curr Opin Lipidol 28(2):91\u201398. https:\/\/doi.org\/10.1097\/mol.0000000000000394","journal-title":"Curr Opin Lipidol"},{"key":"7253_CR9","doi-asserted-by":"publisher","DOI":"10.3390\/cells7080092","author":"CJ Malemud","year":"2018","unstructured":"Malemud CJ (2018) MicroRNAs and osteoarthritis. Cells. https:\/\/doi.org\/10.3390\/cells7080092","journal-title":"Cells"},{"key":"7253_CR10","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.bbi.2015.07.003","volume":"52","author":"W Su","year":"2016","unstructured":"Su W, Aloi MS, Garden GA (2016) MicroRNAs mediating CNS inflammation: small regulators with powerful potential. Brain Behav Immun 52:1\u20138. https:\/\/doi.org\/10.1016\/j.bbi.2015.07.003","journal-title":"Brain Behav Immun"},{"issue":"10","key":"7253_CR11","doi-asserted-by":"publisher","first-page":"1242","DOI":"10.1002\/jnr.24487","volume":"97","author":"J Li","year":"2019","unstructured":"Li J, Li K, Chen X (2019) Inflammation-regulatory microRNAs: valuable targets for intracranial atherosclerosis. J Neurosci Res 97(10):1242\u20131252. https:\/\/doi.org\/10.1002\/jnr.24487","journal-title":"J Neurosci Res"},{"issue":"33","key":"7253_CR12","doi-asserted-by":"publisher","first-page":"12481","DOI":"10.1073\/pnas.0605298103","volume":"103","author":"KD Taganov","year":"2006","unstructured":"Taganov KD et al (2006) NF-kappaB-dependent induction of microRNA miR-146, an inhibitor targeted to signaling proteins of innate immune responses. Proc Natl Acad Sci U S A 103(33):12481\u201312486. https:\/\/doi.org\/10.1073\/pnas.0605298103","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"3","key":"7253_CR13","doi-asserted-by":"publisher","first-page":"2150","DOI":"10.4049\/jimmunol.0900707","volume":"183","author":"J Hou","year":"2009","unstructured":"Hou J et al (2009) MicroRNA-146a feedback inhibits RIG-I-dependent Type I IFN production in macrophages by targeting TRAF6, IRAK1, and IRAK2. J Immunol 183(3):2150\u20132158. https:\/\/doi.org\/10.4049\/jimmunol.0900707","journal-title":"J Immunol"},{"key":"7253_CR14","doi-asserted-by":"publisher","first-page":"204","DOI":"10.1016\/j.intimp.2018.12.043","volume":"68","author":"H Wu","year":"2019","unstructured":"Wu H et al (2019) Extracellular vesicles containing miR-146a attenuate experimental colitis by targeting TRAF6 and IRAK1. Int Immunopharmacol 68:204\u2013212. https:\/\/doi.org\/10.1016\/j.intimp.2018.12.043","journal-title":"Int Immunopharmacol"},{"issue":"1","key":"7253_CR15","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1016\/j.atherosclerosis.2011.07.020","volume":"219","author":"E Raitoharju","year":"2011","unstructured":"Raitoharju E et al (2011) miR-21, miR-210, miR-34a, and miR-146a\/b are up-regulated in human atherosclerotic plaques in the tampere vascular study. Atherosclerosis 219(1):211\u2013217. https:\/\/doi.org\/10.1016\/j.atherosclerosis.2011.07.020","journal-title":"Atherosclerosis"},{"issue":"1","key":"7253_CR16","doi-asserted-by":"publisher","first-page":"e1","DOI":"10.1161\/circresaha.117.305844","volume":"117","author":"K Li","year":"2015","unstructured":"Li K et al (2015) Apolipoprotein E enhances microRNA-146a in monocytes and macrophages to suppress nuclear factor-\u03baB-driven inflammation and atherosclerosis. Circ Res 117(1):e1\u2013e11. https:\/\/doi.org\/10.1161\/circresaha.117.305844","journal-title":"Circ Res"},{"key":"7253_CR17","doi-asserted-by":"publisher","first-page":"9723129","DOI":"10.1155\/2019\/9723129","volume":"2019","author":"GF Zhu","year":"2019","unstructured":"Zhu GF et al (2019) Inflammation-related microRNAs are associated with plaque stability calculated by IVUS in coronary heart disease patients. J Interv Cardiol 2019:9723129. https:\/\/doi.org\/10.1155\/2019\/9723129","journal-title":"J Interv Cardiol"},{"issue":"13","key":"7253_CR18","doi-asserted-by":"publisher","first-page":"1794","DOI":"10.1093\/cvr\/cvy132","volume":"114","author":"D Wang","year":"2018","unstructured":"Wang D et al (2018) Apoptotic cell induction of miR-10b in macrophages contributes to advanced atherosclerosis progression in ApoE-\/- mice. Cardiovasc Res 114(13):1794\u20131805. https:\/\/doi.org\/10.1093\/cvr\/cvy132","journal-title":"Cardiovasc Res"},{"issue":"1","key":"7253_CR19","doi-asserted-by":"publisher","first-page":"12089","DOI":"10.1038\/s41598-017-12167-z","volume":"7","author":"H Chen","year":"2017","unstructured":"Chen H et al (2017) MircroRNA-19a promotes vascular inflammation and foam cell formation by targeting HBP-1 in atherogenesis. Sci Rep 7(1):12089. https:\/\/doi.org\/10.1038\/s41598-017-12167-z","journal-title":"Sci Rep"},{"issue":"2","key":"7253_CR20","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1016\/j.abb.2012.09.007","volume":"528","author":"K Zhang","year":"2012","unstructured":"Zhang K et al (2012) Interleukin 6 destabilizes atherosclerotic plaques by downregulating prolyl-4-hydroxylase \u03b11 via a mitogen-activated protein kinase and c-Jun pathway. Arch Biochem Biophys 528(2):127\u2013133. https:\/\/doi.org\/10.1016\/j.abb.2012.09.007","journal-title":"Arch Biochem Biophys"},{"key":"7253_CR21","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1016\/j.biocel.2018.10.002","volume":"105","author":"XL Wang","year":"2018","unstructured":"Wang XL et al (2018) Rosuvastatin stabilizes atherosclerotic plaques by reducing CD40L overexpression-induced downregulation of P4H\u03b11 in ApoE(-\/-) mice. Int J Biochem Cell Biol 105:70\u201377. https:\/\/doi.org\/10.1016\/j.biocel.2018.10.002","journal-title":"Int J Biochem Cell Biol"},{"issue":"5","key":"7253_CR22","doi-asserted-by":"publisher","first-page":"964","DOI":"10.1097\/hjh.0000000000001979","volume":"37","author":"H Li","year":"2019","unstructured":"Li H et al (2019) Melatonin enhances atherosclerotic plaque stability by inducing prolyl-4-hydroxylase \u03b11 expression. J Hypertens 37(5):964\u2013971. https:\/\/doi.org\/10.1097\/hjh.0000000000001979","journal-title":"J Hypertens"},{"issue":"5","key":"7253_CR23","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1007\/s00109-018-1627-8","volume":"96","author":"WJ Liang","year":"2018","unstructured":"Liang WJ et al (2018) AMPK\u03b1 inactivation destabilizes atherosclerotic plaque in streptozotocin-induced diabetic mice through AP-2\u03b1\/miRNA-124 axis. J Mol Med (Berl) 96(5):403\u2013412. https:\/\/doi.org\/10.1007\/s00109-018-1627-8","journal-title":"J Mol Med (Berl)"},{"key":"7253_CR24","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1016\/j.arr.2017.12.007","volume":"42","author":"H Deng","year":"2018","unstructured":"Deng H, Wang P, Jankovic J (2018) The genetics of Parkinson disease. Ageing Res Rev 42:72\u201385. https:\/\/doi.org\/10.1016\/j.arr.2017.12.007","journal-title":"Ageing Res Rev"},{"issue":"7","key":"7253_CR25","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0101530","volume":"9","author":"W Jiang","year":"2014","unstructured":"Jiang W et al (2014) miR-146a ameliorates liver ischemia\/reperfusion injury by suppressing IRAK1 and TRAF6. PLoS ONE 9(7):e101530. https:\/\/doi.org\/10.1371\/journal.pone.0101530","journal-title":"PLoS ONE"},{"issue":"7","key":"7253_CR26","doi-asserted-by":"publisher","first-page":"743","DOI":"10.1002\/tox.22561","volume":"33","author":"L Liu","year":"2018","unstructured":"Liu L et al (2018) MiR-146a regulates PM(1) -induced inflammation via NF-\u03baB signaling pathway in BEAS-2B cells. Environ Toxicol 33(7):743\u2013751. https:\/\/doi.org\/10.1002\/tox.22561","journal-title":"Environ Toxicol"},{"key":"7253_CR27","doi-asserted-by":"publisher","first-page":"86","DOI":"10.3389\/fcvm.2019.00086","volume":"6","author":"J Petrkova","year":"2019","unstructured":"Petrkova J et al (2019) Increased expression of miR-146a in valvular tissue from patients with aortic valve stenosis. Front Cardiovasc Med 6:86. https:\/\/doi.org\/10.3389\/fcvm.2019.00086","journal-title":"Front Cardiovasc Med"},{"issue":"6","key":"7253_CR28","doi-asserted-by":"publisher","first-page":"1149","DOI":"10.1016\/j.thromres.2015.10.013","volume":"136","author":"J Shen","year":"2015","unstructured":"Shen J et al (2015) The relationship of miR-146a gene polymorphism with carotid atherosclerosis in Chinese patients with type 2 diabetes mellitus. Thromb Res 136(6):1149\u20131155. https:\/\/doi.org\/10.1016\/j.thromres.2015.10.013","journal-title":"Thromb Res"},{"issue":"3","key":"7253_CR29","doi-asserted-by":"publisher","first-page":"2328","DOI":"10.3892\/mmr.2016.5495","volume":"14","author":"JH Sung","year":"2016","unstructured":"Sung JH et al (2016) miRNA polymorphisms (miR-146a, miR-149, miR-196a2 and miR-499) are associated with the risk of coronary artery disease. Mol Med Rep 14(3):2328\u20132342. https:\/\/doi.org\/10.3892\/mmr.2016.5495","journal-title":"Mol Med Rep"},{"issue":"4","key":"7253_CR30","doi-asserted-by":"publisher","first-page":"1202","DOI":"10.1016\/j.jaci.2017.08.034","volume":"141","author":"TX Lu","year":"2018","unstructured":"Lu TX, Rothenberg ME (2018) MicroRNA. J Allergy Clin Immunol 141(4):1202\u20131207. https:\/\/doi.org\/10.1016\/j.jaci.2017.08.034","journal-title":"J Allergy Clin Immunol"},{"key":"7253_CR31","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1016\/j.imlet.2020.07.008","volume":"227","author":"SS Mortazavi-Jahromi","year":"2020","unstructured":"Mortazavi-Jahromi SS, Aslani M, Mirshafiey A (2020) A comprehensive review on miR-146a molecular mechanisms in a wide spectrum of immune and non-immune inflammatory diseases. Immunol Lett 227:8\u201327. https:\/\/doi.org\/10.1016\/j.imlet.2020.07.008","journal-title":"Immunol Lett"},{"issue":"12","key":"7253_CR32","doi-asserted-by":"publisher","first-page":"107725","DOI":"10.1016\/j.jdiacomp.2020.107725","volume":"34","author":"W Guo","year":"2020","unstructured":"Guo W et al (2020) Increased plasma miR-146a levels are associated with subclinical atherosclerosis in newly diagnosed type 2 diabetes mellitus. J Diabetes Complicat 34(12):107725. https:\/\/doi.org\/10.1016\/j.jdiacomp.2020.107725","journal-title":"J Diabetes Complicat"},{"issue":"4","key":"7253_CR33","doi-asserted-by":"publisher","first-page":"354","DOI":"10.1161\/circresaha.116.310529","volume":"121","author":"HS Cheng","year":"2017","unstructured":"Cheng HS et al (2017) Paradoxical suppression of atherosclerosis in the absence of microRNA-146a. Circ Res 121(4):354\u2013367. https:\/\/doi.org\/10.1161\/circresaha.116.310529","journal-title":"Circ Res"},{"key":"7253_CR34","doi-asserted-by":"publisher","first-page":"578","DOI":"10.3389\/fimmu.2014.00578","volume":"5","author":"R Saba","year":"2014","unstructured":"Saba R, Sorensen DL, Booth SA (2014) MicroRNA-146a: a dominant, negative regulator of the innate immune response. Front Immunol 5:578. https:\/\/doi.org\/10.3389\/fimmu.2014.00578","journal-title":"Front Immunol"},{"issue":"5","key":"7253_CR35","doi-asserted-by":"publisher","first-page":"388","DOI":"10.1038\/cmi.2011.26","volume":"8","author":"MA Nahid","year":"2011","unstructured":"Nahid MA, Satoh M, Chan EK (2011) MicroRNA in TLR signaling and endotoxin tolerance. Cell Mol Immunol 8(5):388\u2013403. https:\/\/doi.org\/10.1038\/cmi.2011.26","journal-title":"Cell Mol Immunol"},{"issue":"1","key":"7253_CR36","doi-asserted-by":"publisher","first-page":"1801","DOI":"10.1038\/s41467-019-09588-x","volume":"10","author":"J Ben","year":"2019","unstructured":"Ben J et al (2019) Major vault protein suppresses obesity and atherosclerosis through inhibiting IKK-NF-\u03baB signaling mediated inflammation. Nat Commun 10(1):1801. https:\/\/doi.org\/10.1038\/s41467-019-09588-x","journal-title":"Nat Commun"},{"issue":"7","key":"7253_CR37","doi-asserted-by":"publisher","first-page":"1610","DOI":"10.1161\/atvbaha.106.129957","volume":"27","author":"A Kawamura","year":"2007","unstructured":"Kawamura A et al (2007) Apolipoprotein E interrupts interleukin-1beta signaling in vascular smooth muscle cells. Arterioscler Thromb Vasc Biol 27(7):1610\u20131617. https:\/\/doi.org\/10.1161\/atvbaha.106.129957","journal-title":"Arterioscler Thromb Vasc Biol"}],"container-title":["Molecular Biology Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11033-022-07253-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11033-022-07253-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11033-022-07253-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,7,7]],"date-time":"2022-07-07T22:35:20Z","timestamp":1657233320000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11033-022-07253-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,2,23]]},"references-count":37,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2022,6]]}},"alternative-id":["7253"],"URL":"https:\/\/doi.org\/10.1007\/s11033-022-07253-z","relation":{},"ISSN":["0301-4851","1573-4978"],"issn-type":[{"value":"0301-4851","type":"print"},{"value":"1573-4978","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,2,23]]},"assertion":[{"value":"10 August 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 February 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 February 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"We declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"This study received ethical approval from The Second affiliated hospital of Kunming medical university ethics committee.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}}]}}